医院
北京积水潭医院Beijing Jishuitan Hospital
概览
仅为已发布的数值,每一个都取自本页所依据的记录。其背后的名单见下方章节。
-
复旦大学医院排行榜 A++ 综合榜,2023
-
已发表研究 20 我们为该医院保存的 PubMed 记录(每家医院最新二十条)
-
已登记研究 4 我们为该医院保存的记录,按注册原样
排名与认证
这些名单由运营它们的机构发布,而非本站。每一行都带其发布年份与来源链接;这不是付费或推广位。
复旦大学医院排行榜
| 项目 | 名次/层级 | 年份 | 口径 | 来源 |
|---|---|---|---|---|
| 综合榜 | A++ | 2023 | 仅列层级;同一层级内的医院之间不排序 | https://rank.cn-healthcare.com/fudan/national-general |
面向境外患者
只有在我们持有相应记录时,这里才会出现一行。缺失的行尚未核实——联系我们,我们会向医院提出该问题。
医院详情
- 中文名
- 北京积水潭医院
- 英文名
- Beijing Jishuitan Hospital
以中文写出的数值按来源原样引用。
等级名单的依据是官方名单发布时所依据的日期或评审批次;按来源的语言引用。
该疾病的证据
依据官方公开数据来源筛选
-
Colorectal cancer
已发表研究
- Prognostic Significance of Sarcopenia in Colorectal Cancer: A Review of Clinical Evidence. Cancer management and research, 2026
- The Impact of Prehabilitation on Postoperative Outcomes in Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials. Journal of the American Medical Directors Association, 2026
另有 2 项已发表研究
PubMed 收录了 4 篇关于该疾病、并提及这家医院的论文。
-
Breast cancer
已发表研究
- Enhanced anticancer efficacy of α-lipoic acid-loaded TPGS micelles: Synthesis, characterization, and evaluation in a 4T1 breast cancer model. BioImpacts : BI, 2026
- Spatholobus suberectus Dunn inhibits breast cancer bone metastasis in vitro and in vivo. Journal of traditional and complementary medicine, 2026
另有 1 项已发表研究
PubMed 收录了 3 篇关于该疾病、并提及这家医院的论文。
-
Lung cancer
已发表研究
- Tumor microenvironment-mediated resistance to immune checkpoint inhibitors in non-small cell lung cancer: Mechanisms, combination strategies and clinical perspectives (Review). Molecular and clinical oncology, 2026
PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。
-
Liver cancer
已发表研究
- Spatial multi-omics identifies a NOTCH3-mediated capillary-mCAF crosstalk driving immune exclusion in hepatocellular carcinoma. iMeta, 2026
- Spatial multi omic profiling maps hypoxia-driven pro-fibrotic SPP1(+) macrophages underpinning immune escape and TACE resistance in hepatocellular carcinoma. Experimental hematology & oncology, 2026
PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。
-
Cervical cancer
已发表研究
- Distinct miR319a identified from Persicaria chinensis mediates cross-kingdom suppression of cervical cancer by targeting ITGA3. Acta biochimica et biophysica Sinica, 2026
PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。
-
Stomach cancer
已发表研究
- THSD7B promotes tumor progression and is associated with prognosis in gastric adenocarcinoma. PloS one, 2026
- The disease burden of gastric cancer in China, 1990-2023: A comprehensive analysis and projections to 2035. Clinics and research in hepatology and gastroenterology, 2026
另有 1 项已发表研究
PubMed 收录了 3 篇关于该疾病、并提及这家医院的论文。
-
Prostate cancer
已发表研究
- Fibroblast-associated CTHRC1 as a key indicator of recurrence risk in prostate cancer. World journal of surgical oncology, 2026
- Development and validation of a machine learning-based early warning model for bone metastasis in newly diagnosed prostate cancer. Frontiers in oncology, 2026
另有 2 项已发表研究
PubMed 收录了 4 篇关于该疾病、并提及这家医院的论文。
-
Thyroid cancer
已发表研究
- Microwave ablation for T1N0M0 papillary thyroid carcinoma located in the isthmus: a multicenter prospective cohort study with over 5-year follow-up. Therapeutic advances in medical oncology, 2026
PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。
-
Esophageal cancer
已发表研究
- Habitat-Based Radiomics Model of Pretreatment CT to Predict Pathological Response of Esophageal Squamous Cell Carcinoma to Neoadjuvant Chemoimmunotherapy: A Multicenter Prospective Study. Academic radiology, 2026
PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。
北京市 Beijing 的其他医院
来源与证据
- 来源 URL
- https://rank.cn-healthcare.com/fudan/national-general
- 来源协议
- https
- 来源类型
- 第三方汇编
- 证据等级
- B ——医院自我声明或权威媒体
- 获取日期
- 2026-09-24